Hypoaldosteronism is an endocrinological disorder characterized decreased levels of the hormone aldosterone. Similarly, isolated hypoaldosteronism is the condition of having lowered aldosterone without corresponding changes in cortisol.[1] (The two hormones are both produced by the adrenals.)
Contents
1Causes
2Diagnosis
3Treatment
4Effects
5See also
6References
7External links
Causes
There are several causes for this condition, including adrenal insufficiency, congenital adrenal hyperplasia, and some medications such as certain diuretics, NSAIDs, and ACE inhibitors.
Primary aldosterone deficiency
Primary adrenal insufficiency
Congenital adrenal hyperplasia (21 and 11β but not 17)
Aldosterone synthase deficiency
Secondary aldosterone deficiency
Secondary adrenal insufficiency
Diseases of the pituitary or hypothalamus
Hyporeninemic hypoaldosteronism (due to decreased angiotensin 2 production as well as intra-adrenal dysfunction)[2]
This section is empty. You can help by adding to it. (November 2017)
Treatment
Aldosterone deficiency should be treated with a mineralocorticoid (such as fludrocortisone), as well as possibly a glucocorticoid for cortisol deficiency, if present.
Hyporeninemic hypoaldosteronism is amenable to fludrocortisone treatment,[2] but the accompanying hypertension and edema can prove a problem in these patients, so often a diuretic (such as the thiazide diuretic, bendrofluazide, or a loop diuretic, such as furosemide) is used to control the hyperkalemia.[3]
Effects
Hypoaldosteronism may result in hyperkalemia and is the cause of 'type 4 renal tubular acidosis', sometimes referred to as hyperkalemic RTA or tubular hyperkalemia. However, the acidosis, if present, is often mild. It can also cause urinary sodium wasting, leading to volume depletion and hypotension.
When adrenal insufficiency develops rapidly, the amount of Na+ lost from the extracellular fluid exceeds the amount excreted in the urine, indicating that Na+ also must be entering cells. When the posterior pituitary is intact, salt loss exceeds water loss, and the plasma Na+ falls. However, the plasma volume also is reduced, resulting in hypotension, circulatory insufficiency, and, eventually, fatal shock. These changes can be prevented to a degree by increasing the dietary NaCl intake. Rats survive indefinitely on extra salt alone, but in dogs and most humans, the amount of supplementary salt needed is so large that it is almost impossible to prevent eventual collapse and death unless mineralocorticoid treatment is also instituted.[citation needed]
See also
Addison's disease
Adrenal gland
Hyperaldosteronism
Pseudohypoaldosteronism
References
^Becker, Kenneth L. (2001). Principles and practice of endocrinology and metabolism. Lippincott Williams & Wilkins. pp. 785–. ISBN 978-0-7817-1750-2. Retrieved 15 July 2011.
^ abDeFronzo RA (1980). "Hyperkalemia and hyporeninemic hypoaldosteronism". Kidney Int. 17 (1): 118–34. doi:10.1038/ki.1980.14. PMID 6990088.
^Sebastian A, Schambelan M, Sutton JM (1984). "Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis". Am. J. Nephrol. 4 (5): 287–300. doi:10.1159/000166827. PMID 6524600.
External links
Classification
D
ICD-10: E27.4
MeSH: D006994
DiseasesDB: 20960
v
t
e
Diseases of the endocrine system (E00–E35, 240–259)
Relative hypoaldosteronism in a patient with Wolcott-Rallison syndrome.
Uçar A1, Aydemir Y2, Doğan A3, Tunçez E4.
Diabetic medicine : a journal of the British Diabetic Association.Diabet Med.2016 Mar;33(3):e13-6. doi: 10.1111/dme.12968.
BACKGROUND: Wolcott-Rallison syndrome is an autosomal recessive, multisystem disorder with onset of diabetes in the neonatal period or early infancy.CASE REPORT: A 9-year-old girl with diabetes and growth failure from 2 months of age presented with ketoacidosis and multiple organ failure. Evaluatio
Renal tubular acidosis (RTA) is a rare complication of renal involvement of systemic lupus erythematosus (SLE). We describe a 24-year-old male with type IV lupus nephropathy as a presenting manifestation of SLE. He presented with improvement of renal function following induction therapy with three p
Apparent mineralocorticoid excess and the long term treatment of genetic hypertension.
Razzaghy-Azar M1, Yau M2, Khattab A3, New MI3.
The Journal of steroid biochemistry and molecular biology.J Steroid Biochem Mol Biol.2016 Feb 15. pii: S0960-0760(16)30028-0. doi: 10.1016/j.jsbmb.2016.02.014. [Epub ahead of print]
Apparent Mineralocorticoid Excess (AME) is a genetic disorder causing severe hypertension, hypokalemia, and hyporeninemic hypoaldosteronism owing to deficient 11 beta-hydroxysteroid dehydrogenase type-2 (11βHSD2) enzyme activity. The 11βHSD2 enzyme confers mineralocorticoid receptor specificity fo
Hypoaldosteronism - Mineralocorticoid Deficiency Aldosterone deficiency syndromes [REF: Scientific American Medicine 2000] Occasionally, aldosterone deficiency is the only, or predominant, sign of adrenal ...
hypoaldosteronism [hi″po-al-dos´ter-ōn-izm] deficiency of aldosterone in the body. hy·po·al·dos·ter·on·ism (hī'pō-al-dos'tĕr-on-izm), A condition due to deficient secretion of aldosterone; can occur in two forms: as part of generalized ...